Clinical Trial

Assessing DCog Short for Neurotoxicity in CAR-T

Name: Assessing DCog Short for Neurotoxicity in CAR-T — clinical trial record (NCT07403812)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to determine the effectiveness of DCog Short, a self-reporting, iPad-based application tool, in assessing neurotoxicity in participants undergoing CAR-T cell therapy.

Trial Details

NCT Number	NCT07403812
Lead Sponsor	Beth Israel Deaconess Medical Center
Conditions	Neurotoxicity, Neurotoxicity Syndromes, Hematologic Malignancy, Immune Effector Cell Associated Neurotoxicity Syndrome
Enrollment	40 participants
Start Date	2026-07
Primary Completion	2026-08-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-11